Both in Pharmaceuticals
Kyntra Bio vs Citius Pharmaceuticals
Over the past year KYNB returned −58.3% and CTXR returned −38.8%; their daily moves had a correlation of 0.07.
KYNB −58.3% CTXR −38.8%Growth of $1, one year, split-adjusted
| Metric | KYNB | CTXR |
|---|---|---|
| Price | $3.96 | $0.5510 |
| Market cap | $16.0M | $15.1M |
| Today | −8.12% | −3.87% |
| 1 month | −33.6% | +14.6% |
| 6 months | −44.4% | −17.3% |
| Year to date | — | −29.1% |
| 1 year | — | −63.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −593.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $91.3M | $10.6M |
| Dividend yield | — | — |
| Volatility (60d) | 57.0% | 96.0% |
| Short % of float | 2.5% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).